About
Customized membrane protein products, services and expertise
Areas of Focus
Categories
Non-PharmaceuticalContract ResearchContract ResearchServicesSingapore
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
1
As Collaborator
1
Total Enrollment
78
By Phase
PHASE1: 2
By Status
RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06587295Collaborator
Intramuscular ACM-CpG Monotherapy in Patients With Advanced/Metastatic Solid Tumors With Prior Response to Immunotherapy Alone or in Combination With Chemotherapy
PHASE1Recruiting
40 participants
Started: Jan 15, 2025 · Completed: Dec 31, 2026
NCT05385991Lead Sponsor
Booster Dose Study to Assess the Safety and Immunogenicity of ACM-001 Administered Intramuscularly or Intranasally.
PHASE1Completed
38 participants
Started: Jul 1, 2022 · Completed: Aug 22, 2023
Locations (1)
Headquarters
Singapore, Singapore
Map
Loading map...